Findings presented at the International VT Symposium and published simultaneously in Circulation. CARDIFF-BY-THE-SEA, Calif. and PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ -- Field Medical, Inc. today announced that Circulation has published six-month outcomes from the Ventricular Catheter...
Hence then, the article about circulation publishes 6 month outcomes from first in human vcas trial of fieldforce pulsed field ablation system 82 freedom from vt vf recurrence and 98 reduction in burden was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden )
Also on site :
- 10 WORKING DAYS TO READ: PRIVACY FINE PRINT BEHIND A FAMILY'S DIGITAL DAY MORE THAN SHAKESPEARE'S COMPLETE WORKS, NEW STUDY FINDS
- Telesur Successfully Upgrades to Cerillion 26.1, Unlocking Advanced Promotions and AI-Driven Innovation
- Under Trump, Commodity Futures Trading Commission Scales Back Enforcement, Worrying Farmers